immunosuppress
caus
bovin
viral
diarrhea
viru
bvdv
associ
lymphocyt
deplet
leukopenia
impair
leukocyt
function
howev
work
done
relationship
bvdv
regulatori
lymphocyt
treg
object
studi
compar
mrna
express
gene
associ
treg
ido
experiment
infect
beef
calv
low
lv
high
hv
virul
bvdv
thirti
calv
randomli
assign
three
group
calv
intranas
inocul
lv
n
strain
hv
n
strain
bvdv
bvdvfree
cell
cultur
medium
control
n
quantit
rtpcr
use
determin
express
target
gene
tracheobronchi
lymph
node
spleen
day
postinfect
mrna
express
upregul
tracheobronchi
lymph
node
lv
p
hv
compar
control
group
express
increas
tracheobronchi
lymph
node
either
bvdvinocul
group
dramat
upregul
ido
mrna
observ
tracheobronchi
lymph
node
lv
p
hv
compar
control
calv
conclus
experiment
infect
bvdv
provid
evid
treg
activ
base
express
differenti
express
ido
mrna
day
postinfect
hv
lv
bvdv
might
reflect
tempor
differ
transcript
occur
immun
respons
elicit
viral
strain
differ
viral
infect
host
cell
immunosuppress
caus
bovin
viral
diarrhea
viru
bvdv
associ
lymphocyt
deplet
leukopenia
impair
leukocyt
function
howev
work
done
relationship
bvdv
regulatori
lymphocyt
treg
object
studi
compar
mrna
express
gene
associ
treg
ido
experiment
infect
beef
calv
low
lv
high
hv
virul
bvdv
thirti
calv
randomli
assign
three
group
calv
intranas
inocul
lv
n
strain
hv
n
strain
bvdv
bvdvfree
cell
cultur
medium
control
n
quantit
rtpcr
use
determin
express
target
gene
tracheobronchi
lymph
node
spleen
day
postinfect
mrna
express
upregul
tracheobronchi
lymph
node
lv
p
hv
compar
control
group
express
increas
tracheobronchi
lymph
node
either
bvdvinocul
group
dramat
upregul
ido
mrna
observ
tracheobronchi
lymph
node
lv
p
hv
compar
control
calv
conclus
experiment
infect
bvdv
provid
evid
treg
activ
base
express
differenti
express
ido
mrna
day
postinfect
hv
lv
bvdv
might
reflect
tempor
differ
transcript
occur
immun
respons
elicit
viral
strain
differ
viral
infect
host
cell
publish
elsevi
ltd
bovin
viral
diarrhea
viru
bvdv
import
pathogen
affect
cattl
industri
worldwid
bvdv
caus
respiratori
reproduct
gastrointestin
diseas
acut
infect
noncytopath
ncp
bvdv
transient
selflimit
howev
viru
associ
increas
host
suscept
http
elsevi
ltd
secondari
infect
believ
group
virus
induc
immunosuppress
viral
infect
combin
secondari
infect
result
sever
polymicrobi
clinic
diseas
immunosuppress
caus
bvdv
associ
lymphocyt
deplet
leukopenia
impair
leukocyt
function
howev
publish
work
done
relationship
bvdv
induct
suppressor
lymphocyt
activ
cell
express
transcript
factor
forkheadbox
repres
popul
immunosuppress
cell
call
tregulatori
cell
treg
cell
respons
modul
immun
system
maintain
homeostasi
inhibit
function
activ
effector
cell
previou
report
indic
treg
function
mammalian
speci
far
examin
includ
cattl
review
garden
et
al
express
transcript
factor
current
util
defin
marker
treg
howev
neg
cell
regulatori
function
also
exist
intranuclear
protein
play
major
role
develop
function
treg
addit
function
treg
often
express
cytotox
tlymphocyt
antigen
surfac
protein
receptor
associ
transmiss
inhibitori
signal
cell
capabl
regul
adapt
immun
respons
moreov
treg
cell
induc
express
enzym
indoleamin
ido
antigen
present
cell
enzym
degrad
tryptophan
limit
immun
cell
activ
lack
essenti
amino
acid
inhibit
tcell
activ
promot
tcell
apoptosi
induct
treg
mechan
describ
infect
virus
human
immunodefici
viru
hiv
hepat
c
viru
hcv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
lymphotrop
viru
htlv
vaccinia
viru
vacv
hepat
b
viru
hbv
porcin
reproduct
respiratori
syndrom
viru
prrsv
simian
immunodefici
viru
siv
felin
immunodefici
viru
fiv
believ
treg
gener
suppress
immun
respons
allow
viru
evad
immun
respons
infect
recent
studi
demonstr
induct
treg
earli
phase
acut
infect
prrsv
moreov
increas
frequenc
cell
infect
prrsv
pig
associ
increas
secret
recogn
immunosuppress
function
product
induc
natur
treg
induct
cell
subset
could
explain
delay
prrsv
cell
mediat
immun
commonli
observ
prr
induc
immunosuppress
infect
pig
defin
classic
cours
infect
therefor
upregul
treg
associ
gene
calv
infect
bvdv
could
indic
role
cell
subset
bvdv
pathogenesi
hypothes
acut
infect
ncp
bvdv
would
upregul
mrna
express
gene
associ
treg
lymphoid
tissu
beef
calv
also
hypothes
high
virul
ncp
would
induc
significantli
stronger
express
mrna
gene
associ
treg
cours
infect
low
virul
ncp
goal
set
assess
elucid
differ
gene
express
lymphoid
tissu
calv
infect
high
low
virul
bvdv
like
associ
immunosuppress
cours
clinic
diseas
particularli
light
character
mrna
express
type
interferon
proapoptot
signal
proinflammatori
antiinflammatori
cytokin
respons
alreadi
publish
tissu
object
studi
evalu
mrna
express
gene
associ
treg
ido
lymphoid
tissu
earli
acut
infect
noncytopath
ncp
bvdv
beef
calv
compar
mrna
express
treg
gene
lymphoid
tissu
earli
acut
infect
high
strain
low
strain
virul
strain
bvdv
studi
perform
use
sampl
previou
experiment
trial
total
thirti
beef
calv
month
old
enrol
calv
clinic
normal
free
bvdv
base
viru
isol
serum
immunohistochem
stain
ear
notch
biopsi
calv
seroneg
base
serum
viru
neutral
assay
measur
dilut
anim
obtain
farm
own
auburn
univers
locat
huntsvil
al
farm
manag
close
biosecur
program
allow
introduct
new
anim
anim
transport
farm
origin
auburn
univers
farm
document
bvdv
posit
anim
three
day
begin
studi
studi
design
random
control
trial
calv
randomli
assign
use
random
number
gener
research
random
wwwrandomizerorg
one
three
treatment
group
lv
n
anim
challeng
low
virul
type
ncp
bvdv
strain
hv
n
anim
challeng
high
virul
type
ncp
bvdv
strain
control
n
receiv
cell
cultur
medium
without
bvdv
calv
hous
togeth
farm
free
bvdv
prior
inocul
treatment
group
inocul
separ
transport
auburn
univers
bvdv
isol
farm
locat
mile
away
origin
farm
except
control
group
remain
origin
farm
throughout
experiment
period
addit
avoid
shed
exchang
bvdv
among
group
prevent
accident
bvdv
infect
control
group
studi
perform
three
sequenti
round
inocul
necropsi
spatial
tempor
separ
first
week
calv
assign
lv
group
separ
main
group
transport
bvdvisol
unit
inocul
lv
calv
stay
bvdv
isol
farm
day
postinfect
day
calv
euthan
bodi
transport
necropsi
depart
pathobiolog
colleg
veterinari
medicin
auburn
univers
second
week
anim
assign
control
group
gather
togeth
load
transport
approxim
min
around
geograph
area
calv
return
pastur
origin
farm
transport
perform
provid
similar
manag
condit
group
origin
farm
control
calv
separ
remain
calv
maintain
differ
pastur
day
posttransport
mock
challeng
calv
control
group
euthan
transport
necropsi
second
fourth
week
bvdvinfect
calv
bvdv
isol
farm
quiescent
period
allow
viral
clearanc
environ
farm
desir
prevent
coinfect
hv
group
infect
lv
bvdv
strain
calv
transport
bvdv
isol
farm
report
bvdv
surviv
cool
protect
environ
sever
day
addit
departur
lv
group
arriv
hv
group
concret
floor
chute
pen
bvdv
isol
farm
disinfect
use
bleach
sodium
hypochlorit
naocl
final
fifth
week
anim
assign
hv
group
collect
transport
bvdvisol
farm
experiment
inocul
day
postinfect
hv
calv
euthan
bodi
transport
necropsi
farm
calv
group
lv
hv
control
hous
togeth
pastur
allow
eat
drink
feeder
water
trough
anim
protocol
review
approv
institut
anim
care
use
committe
iacuc
auburn
univers
calv
experiment
inocul
lv
strain
hv
strain
ncp
bvdv
isol
strain
origin
isol
persist
infect
heifer
strain
origin
isol
sever
acut
bvdv
outbreak
ontario
canada
stock
bvdv
strain
use
present
studi
biolog
clone
via
success
passag
madindarbi
bovin
kidney
mdbk
cell
use
limit
dilut
method
subsequ
minim
propag
incub
mdbk
monolay
h
c
co
produc
adequ
amount
stock
viru
desir
cell
cultur
infecti
dose
ccid
ml
character
anim
challeng
exposur
studi
viru
obtain
follow
freezethaw
cycl
disrupt
cell
releas
viral
particl
inoculum
cell
cultur
supernat
store
c
day
use
freez
viral
batch
aliquot
bvdv
inoculum
titrat
madindarbi
bovin
kidney
mdbk
cell
detect
use
immunohistochem
detect
infect
cell
titer
calcul
use
reedmuench
method
determin
final
ccid
ml
inocul
challeng
viru
aliquot
ml
individu
tube
within
h
prior
inocul
store
ice
use
inoculum
use
consist
cell
cultur
supernat
contain
ccid
ml
strain
ccid
ml
strain
viru
suspend
dulbecco
modifi
eagl
medium
dmem
supplement
equin
serum
lalanyl
lglutamin
inocul
perform
intranas
aerosol
ml
inoculum
aerosol
vacuum
pump
one
addit
sampl
inoculum
transport
ice
farm
subsequ
return
lab
immedi
determin
ccid
ml
inocul
complet
determin
minim
viral
challeng
procedur
day
post
challeng
anim
euthan
use
captiv
bolt
devic
bodi
transport
necropsi
full
gross
microscop
examin
perform
calv
tissu
sampl
collect
spleen
tracheobronchi
lymph
node
gene
assess
immedi
tissu
collect
fresh
sampl
submerg
ml
rnase
inhibitor
order
prevent
rna
degrad
stabil
sampl
store
c
process
viru
isol
spleen
sampl
perform
confirm
bvdv
infect
inocul
anim
viru
isol
l
macer
sampl
approxim
cm
tissu
ml
dmem
ad
individu
cm
tissu
cultur
flask
contain
monolay
mdbk
cell
follow
incub
day
final
assess
infect
plate
use
immuneperoxidas
stain
previous
describ
spleen
tracheobronchi
lymph
node
tissu
sampl
approxim
mg
disrupt
homogen
buffer
contain
guanidin
isothiocyan
use
bullet
blender
mm
glass
bead
total
rna
quantit
real
time
rtpcr
qrtpcr
extract
tabl
primer
use
quantit
rtpcr
mrna
express
analysi
gene
associ
function
popul
regulatori
lymphocyt
ido
experiment
challeng
low
strain
high
strain
virul
noncytopath
bvdv
beef
calv
purifi
spleen
tracheobronchi
lymph
node
sampl
use
rna
extract
kit
accord
manufactur
protocol
follow
extract
total
rna
concentr
determin
use
spectrophotomet
nanodrop
synthesi
cdna
perform
g
total
rna
templat
use
first
cdna
strand
revers
transcript
kit
accord
manufactur
protocol
revers
transcript
final
cdna
product
concentr
approxim
gl
total
volum
l
synthes
cdna
dilut
rnase
free
water
reach
templat
concentr
approxim
ngl
use
qrtpcr
four
aliquot
prepar
cdna
sampl
order
avoid
consecut
freezingthaw
event
could
affect
cdna
integr
concentr
primer
pair
pcr
protocol
previous
optim
identifi
condit
gener
singl
amplicon
fluoresc
signal
show
ct
valu
less
dissoci
curv
predict
melt
temperatur
qrtpcr
perform
l
reaction
amplifi
target
gene
sequenc
determin
rel
mrna
level
use
abi
real
time
pcr
system
sybr
green
dna
detect
system
pcr
mix
l
prepar
use
l
master
mix
l
dd
h
l
primer
final
concentr
final
l
cdna
templat
ngl
ad
pcr
reaction
conduct
c
min
preincub
follow
cycl
c
denatur
c
primer
depend
anneal
c
extens
upon
complet
qrtpcr
amplif
melt
curv
analysi
perform
evalu
specif
qualiti
amplif
melt
curv
analysi
done
incub
qrtpcr
product
step
temperatur
gradual
increas
cs
c
sampl
analyz
triplic
increas
accuraci
result
averag
run
use
calcul
rel
amount
mrna
nontempl
neg
control
concurr
run
sampl
replac
templat
dna
pcrgrade
water
rneasi
mini
kit
qiagen
valencia
ca
usa
roch
indianapoli
usa
appli
biosystem
power
sybr
green
pcr
master
mix
normal
rel
quantif
target
gene
qrtpcr
procedur
yield
cross
point
threshold
cycl
ct
fundament
quantit
unit
correspond
pcr
cycl
wherein
amount
dna
amplifi
gene
gener
fluoresc
signal
significantli
higher
baselin
ct
valu
therefor
correl
neg
amount
target
mrna
ie
greater
amount
mrna
sampl
sooner
threshold
reach
lower
ct
valu
obtain
result
gene
express
assess
analyz
use
compar
ct
method
gene
express
analysi
perform
calcul
rel
quantiti
mrna
fold
express
target
gene
normal
housekeep
gene
rrna
unaffect
studi
condit
compar
result
uninfect
control
group
addit
comparison
bvdvchalleng
group
control
group
done
contrast
differ
ct
valu
obtain
target
gene
refer
gene
ct
method
housekeep
gene
dehydrogenas
gapdh
rrna
use
endogen
refer
gene
effici
qrtpcr
determin
primer
creat
standard
amplif
curv
use
ng
ng
ng
ng
per
reaction
cdna
templat
target
gene
target
gene
specif
primer
sequenc
document
tabl
data
analyz
use
statist
analysi
system
version
sa
institut
cari
nc
sampl
size
calcul
use
power
calcul
proc
power
sa
basi
expect
mean
target
gene
express
level
foldregul
mrna
level
normal
housekeep
gene
rel
control
group
experiment
group
sd
foldregul
mean
statist
power
base
previou
measur
earlier
studi
statist
parametr
assumpt
normal
constant
varianc
test
use
shapiro
wilk
leven
test
respect
addit
normal
probabl
residu
quartilequartil
plot
construct
analyz
confirm
signific
departur
normal
constant
variabl
data
sinc
rel
mrna
express
data
normal
distribut
heavili
skew
heterogen
varianc
comparison
mean
gene
express
data
logarithm
transform
outcom
produc
transform
examin
possibl
violat
tent
assumpt
normal
gener
linear
model
procedur
proc
glm
use
analysi
varianc
compar
rel
mrna
level
target
gene
among
group
use
least
signific
differ
lsd
test
differ
pvalu
less
consid
statist
signific
two
calv
lv
group
euthan
due
reason
relat
bvdv
infect
eg
bone
fractur
due
aggress
tempera
calv
studi
bvdv
neg
day
experiment
inocul
day
basi
viru
isol
serum
sampl
bvdv
isol
spleen
sampl
anim
lv
hv
group
day
challeng
demonstr
acut
infect
bvdv
inocul
calv
contrast
spleen
sampl
control
group
bvdv
neg
end
experiment
period
data
previous
publish
level
mrna
express
differ
tracheobronchi
lymph
node
calv
inocul
hv
lv
bvdv
day
inocul
mrna
express
receptor
chain
upregul
tracheobronchi
lymph
node
calv
lv
group
compar
control
group
p
tabl
comparison
ct
method
calv
experiment
challeng
hv
bvdv
show
signific
increas
mrna
level
tracheobronchi
lymph
node
day
post
inocul
addit
mrna
level
significantli
higher
p
tracheobronchi
lymph
node
calv
lv
group
compar
calv
hv
group
fig
comparison
ct
method
transcript
level
gene
spleen
group
bvdvinocul
calv
differ
uninfect
control
calv
p
tabl
comparison
ct
method
express
increas
tracheobronchi
lymph
node
spleen
sampl
either
bvdvinocul
group
compar
control
group
tabl
comparison
ct
method
signific
differ
found
express
group
fig
fig
observ
day
post
inocul
tracheobronchi
lymph
node
calv
lv
group
rel
control
calv
p
tabl
comparison
ct
method
signific
differ
mrna
express
level
ido
tracheobronchi
lymph
node
lv
hv
group
p
fig
comparison
ct
method
contrast
mrna
express
ido
spleen
sampl
calv
inocul
bvdv
similar
observ
control
calv
tabl
p
comparison
ct
method
signific
upregul
mrna
express
observ
calv
lv
group
calv
hv
group
show
signific
increas
mrna
express
compar
control
group
result
appear
indic
upregul
alpha
chain
greater
day
postinfect
lv
infect
calv
might
relat
context
immun
respons
lv
infect
relat
clonal
expans
earli
induct
treg
cell
highli
virul
strain
respons
caus
sever
acut
diseas
associ
greater
reduct
circul
lymphocyt
lymphoid
deplet
vivo
recent
report
show
calv
inocul
highli
virul
strain
signific
reduct
lymphocyt
count
day
post
infect
compar
calv
infect
low
virul
strain
control
group
observ
lymphopenia
infect
might
occur
consequ
lymphocyt
apoptosi
andor
necrosi
previous
observ
deplet
leukocyt
could
respons
lower
mrna
express
gene
associ
treg
marker
previou
studi
ridpath
et
al
shown
decreas
replic
cell
increas
fraction
dead
cell
cultur
lymphoid
cell
line
vitro
infect
highli
virul
strain
hand
infect
low
virul
viru
appar
effect
cell
health
replic
might
support
observ
differenti
mrna
express
express
increas
tracheobronchi
lymph
node
spleen
sampl
either
bvdvinocul
group
thu
experiment
condit
infect
ncp
bvdv
either
lv
hv
group
demonstr
upregul
express
gene
consid
hallmark
treg
activ
lymphoid
tissu
day
post
infect
induct
treg
associ
infect
virus
hiv
hcv
hbv
cmv
hbv
vacv
influenza
viru
coronaviru
arteriviru
prrsv
siv
fiv
propos
activ
treg
cell
gener
suppress
immun
provid
mechan
viru
evad
immun
respons
sever
speci
recent
studi
demonstr
induct
treg
earli
phase
acut
infect
prrsv
moreov
increas
frequenc
cell
infect
prrsv
pig
associ
increas
product
inhibitori
cytokin
tgfbeta
lymphocyt
suppress
activ
vitro
increas
suscept
natur
mycoplasma
hyopneumonia
infect
induct
cell
subset
could
explain
decreas
delay
local
system
prrsvdirect
cell
mediat
immun
prr
infect
gener
immunosuppress
observ
acut
infect
pig
furthermor
human
suppress
virusspecif
immun
associ
increas
express
treg
associ
gene
patient
infect
hiv
may
contribut
uncontrol
viral
replic
consequ
lead
inflammatori
damag
secondari
infect
hiv
infect
previou
studi
shown
induct
regulatori
cell
suppressor
activ
cattl
infect
mycobacterium
avium
subsp
paratuberculosi
moreov
walz
et
al
show
upregul
transcript
level
placentom
heifer
infect
strain
compar
uninfect
control
heifer
author
conclud
immun
recognit
bvdv
maternalfet
interfac
viru
may
alter
normal
express
regulatori
cell
marker
transcript
factor
previous
describ
master
regul
develop
function
suppressor
regulatori
cell
thu
regulatori
cell
typic
defin
express
howev
activ
human
cell
transient
express
certain
condit
neg
cell
regulatori
function
also
demonstr
exist
interestingli
ex
vivo
experi
perform
hoek
et
al
show
evid
bovin
high
cell
popul
suppress
regulatori
cell
studi
cell
signific
cell
popul
calf
blood
show
modulatori
properti
transcrib
strong
upregul
ido
mrna
level
detect
day
post
challeng
tracheobronchi
lymph
node
calv
lv
group
inhibitori
molecul
produc
antigen
present
cell
commonli
associ
pregnanc
relat
immun
suppress
protect
develop
fetu
matern
reject
addit
report
previous
associ
ido
product
viral
infect
influenza
viru
hepat
c
viru
hiv
enhanc
tryptophan
degrad
enzym
contribut
importantli
diseas
progress
clinic
complic
hiv
patient
present
studi
signific
increas
ido
mrna
level
observ
day
post
challeng
calv
experiment
infect
strain
contrast
lv
bvdv
infect
yield
highli
signific
increas
ido
mrna
level
differenti
express
ido
mrna
calv
inocul
bvdv
differ
virul
might
associ
specif
viru
differ
tempor
regul
transcript
process
immun
respons
greater
efficaci
infect
macrophag
dendrit
cell
strain
antigenpres
cell
major
role
ido
product
present
studi
confound
effect
bvdv
genotyp
might
influenc
differ
express
gene
marker
use
two
type
bvdv
strain
differ
virul
might
clearli
shown
specif
effect
virul
present
studi
design
recreat
scenario
compar
bvdv
infect
like
occur
natur
field
quit
common
find
infect
low
virul
viru
higher
virul
viru
field
howev
virus
low
virul
preval
studi
examin
bvdv
isol
cattl
deriv
diagnost
laboratori
submiss
shown
genotyp
frequent
isol
field
studi
isol
compar
genotyp
anim
bovin
respiratori
diseas
complex
bvdv
infect
subclin
howev
bvdv
consid
strong
potenti
secondari
infect
even
mild
infect
provid
observ
clinic
sign
consequ
abil
bvdv
caus
gener
clinic
immunosuppress
result
polymicrobi
respiratori
diseas
reason
use
model
base
two
differ
genotyp
mrna
express
ido
upregul
tracheobronchi
lymph
node
spleen
calv
lv
group
reflect
spatial
regul
transcript
sinc
experiment
challeng
done
intranas
differenti
express
lymphoid
organ
may
due
level
viral
replic
induc
lv
viru
tissu
local
inocul
short
durat
challeng
conclus
experiment
infect
ncp
bvdv
provid
expect
evid
treg
activ
day
post
infect
base
strongli
enhanc
express
gene
function
associ
gene
also
affect
either
lv
hv
bvdv
infect
day
post
infect
differenti
express
ido
mrna
fifth
day
infect
calv
inocul
high
low
virul
bvdv
might
reflect
differ
subpopul
leukocyt
activ
hv
lv
virus
earli
phase
infect
possibl
lv
infect
yield
ido
mediat
suppressor
activ
interact
macrophag
dendrit
cell
activ
lymphocyt
express
alpha
chain
receptor
hv
viru
may
interact
differ
leukocyt
subpopul
possibl
enhanc
damag
induc
pathway
eg
product
differenti
express
gene
hv
lv
infect
fifth
day
infect
may
also
reflect
temporalspati
differ
sequenc
transcript
event
occur
immun
respons
two
viral
strain
may
due
specif
bvdv
genotyp
differ
viral
infect
host
cell
overal
experiment
condit
analysi
mrna
express
gene
associ
regulatori
lymphocyt
ido
fifth
day
infect
ncp
bvdv
provid
solid
basi
postul
role
classic
treg
cell
earli
pathogenesi
bvdv
infect
differenti
pathogenesi
high
low
virul
bvdv
strain
